Results 31 to 40 of about 7,344,621 (307)
Pediatric Blood &Cancer, EarlyView.ABSTRACT Rates of cancer among adolescents and young adults (AYA), age 15–39 years, are increasing. Consequently, radiation oncologists are treating more AYAs who have diagnoses spanning both pediatric and adult practices. Compared to pediatric and older adult patients, AYAs face a unique set of challenges.
Hesham Elhalawani +7 more
wiley +1 more source
The Pyschoactive Politics Framework and the Beginning of Coca Eradication in Peru
Colombia Internacional, 2022 Objective/Context: The present article develops a theoretical tool to explain drug policy decisions called the Psychoactive Politics Framework. It is built on the assumption that the design and implementation of drug policies affect several political ...
Nicolas Alexander Beckmann
doaj +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Febrile neutropenia (FN) is a frequent and serious complication in children receiving cancer therapy. Standardizing FN management across Asia is challenging due to variable healthcare infrastructure, diagnostic capacity, and infection patterns; however, it could improve resource use and patient outcomes.
Joliza Patricia Cañeba +29 more
wiley +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background and Aims Infant bone and soft tissue neoplasms present distinct clinical challenges and lack large‐scale data to inform treatment decisions. This study aims to characterize bone and soft tissue neoplasms in infants in Canada and to compare their outcomes with those of older pediatric patients.
Samuel Sassine +21 more
wiley +1 more source
National drug policy 2015 to 2020 [PDF]
, 2015 Overview Over a lifetime, 44 percent of New Zealanders will try an illegal drug and 93 percent will drink alcohol. While not every instance of alcohol and other drug use is harmful, the effects of these substances can be significant.
Ministry of Health (New Zealand)
core
Molecular Oncology, EarlyView.High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira +7 more
wiley +1 more source
Erroneous formulation of delayed-release omeprazole capsules: alert for importing countries
BMC Pharmacology and Toxicology, 2017 Background Poor drug quality is a matter of serious concern, especially in countries where drug regulation and law enforcement are constrained by limited resources.
Mohammad Sofiqur Rahman +9 more
doaj +1 more source
Revue Interventions Économiques, 2020 From 1995 to 2006, Canadian trade policy purported to insulate the Canadian health care system from the effects of trade liberalization, largely through reliance upon key general exclusion clauses in the NAFTA and the GATS and other legal strategies ...
Mark Crawford
doaj +1 more source
Innovare Journal of Life Sciences, 2020 Pharmaceutical industry is crucial for mankind and contributes in some way in socio economic development of the society through jobs, community welfare, and supply chains. Indian pharmaceutical companies are one of the largest markets in the world, estimated 10% of global production and 2% of world market.
openaire +3 more sources
Taking stock: A decade of drug policy - A civil society shadow report. [PDF]
, 2018 Taking stock: A decade of drug policy’ evaluates the impacts of drug policies implemented across the world over the past decade, using data from the United Nations (UN), complemented with peer-reviewed academic research and grey literature reports from ...
core